While the methylation frequency of some of them (p14ARF, p16INK4A, and MGMT) has been widely assessed in high-grade astrocytomas, it has not been much studied in low-grade astrocytic tumors. The gene discussed is CDKN2A; the disease is astrocytoma (excluding glioblastoma).